IMpower 133 Trial and Patient Selection for Durvalumab + Chemotherapy vs Atezolizumab + Chemotherapy

Video

Dr Charu Aggarwal shares data from the IMpower133 trial of atezolizumab plus chemotherapy for SCLC, and how to select the appropriate frontline therapy.

Related Videos
A panel of 4 experts on MDS
A panel of 4 experts on MDS
A panel of 6 experts on follicular lymphoma and mantle cell lymphoma seated at a long desk
A panel of 5 experts on multiple myeloma
A panel of 5 experts on multiple myeloma
Pasi A. Jänne, MD, PhD, director, Lowe Center for Thoracic Oncology, director, Belfer Center for Applied Cancer Science, director, Chen-Huang Center for EGFR Mutant Lung Cancers, senior physician, David M. Livingston, MD, Chair, Dana-Farber Cancer Institute; professor, medicine, Harvard Medical School
A panel of 4 experts on hematologic malignancies
A panel of 6 experts on chronic lymphocytic leukemia seated at a long desk